CLINICAL_TRIALS
trial_result
· 2019-07-01
Clinical Trial Update: Study of the Vascular Effects of Serelaxin [Phase 2]
Summary
Phase 2 study assessing vascular effects of serelaxin in coronary artery disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-07-01